It also showed that the concentration of protein-bound CML varied little between animals and, more importantly, did not change significantly after an oral exposure to dCML in whatever form it was administrated (free or protein-bound). This evidence concerns the gene GATA2 and chronic myelogenous leukemia, BCR-ABL1 positive.